Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.

Clinical trial NCT02097849 · COMPLETED

Trial details

NCT number: NCT02097849
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing Forms of Multiple Sclerosis

Start date: 2015-02-28
Primary completion: 2016-05-02
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.